ResearchSafe

PE 22-28: Rapid Antidepressant? My Skeptical Take on the Preclinical Buzz

Posted by amber464 in Research & News - 1 points, 4 comments.

I was scrolling through the ResearchSafe site and landed on the PE 22-28 page. The article talks about a synthetic spadin‑derived peptide that blocks the TREK‑1 channel and shows a rapid antidepressant effect in mice. The data look clean: a single injection gave mood‑boosting behavior in the forced swim test within hours, and there were signs of increased synaptogenesis.

For me it’s a classic example of preclinical hype. I’ve been tracking nootropic stacks for years and have seen a lot of “fast‑acting” claims that don’t translate to humans. The half‑life is short and the safety profile is basically unknown.

I’m not dismissing the mechanism – TREK‑1 is a fascinating target – but I’m curious about how fast a human dose could work, what side effects might show up, and whether the rapid effect in mice would even be clinically meaningful. Does anyone have thoughts on moving from rodent to human trials, or ideas on how to monitor safety in an early open‑label study?

Comments

  • aspiring_codes: I get where you’re coming from. When I first started looking at short‑acting peptides, I was cautious about any rodent “rapid” effect and jumped straight to the safety side. With BPC_DEV I ended up doing a very low dose, twice a week, and monitored liver enzymes, CBC, and blood }, I’d ask the group what they’re planning for early safety checks, maybe baseline and 24‑hour vitals, plus weekly labs for a month. In humans the brain‑penetrant dose can be hit‑and‑miss; we’ve seen mild headaches or di
  • amber464: I’m doing something similar, baseline CBC, CMP, and a 24‑hour pulse‑ox/HRV check before the first dose. Then I pause 48 hrs, re‑measure vitals, and do weekly labs for the first month. I’ve logged headaches in a few people, so I watch HRV trends closely. Do you use HRV in your safety protocol?
  • raj353: tbh I’ve kept it pretty straight‑forward too, baseline labs, a 24‑hour vitals check the first time, then daily symptom logs for the week and weekly CBC/LFTs for a month. If any values jump or I see arrhythmias I pause. How do you handle post‑dose vitals? 🔥
  • amber464: I’m doing something similar – after my first PE 22‑28 shot I recorded HR, BP and SpO2 every two hours for the first 24 h, plus a quick orthostatic check. Anything over a 10 bpm swing or a systolic jump >15 mmHg I flag. I also log subjective jitter, sleep latency and any mood shifts in a spreadsheet. Your 24‑hour vitals window lines up with what I’ve found useful, so I’ll keep that as my baseline going forward.

Community discussion - research and educational context only. Not medical advice.